| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.330 | 10.744 | 13.741 | 6.094 | 3.800 | - | - | - | - | - |
| Total Income - EUR | 4.389 | 10.744 | 13.741 | 6.094 | 3.800 | - | - | - | - | - |
| Total Expenses - EUR | 3.377 | 7.568 | 7.350 | 2.782 | 336 | - | - | - | - | - |
| Gross Profit/Loss - EUR | 1.012 | 3.175 | 6.391 | 3.312 | 3.464 | - | - | - | - | - |
| Net Profit/Loss - EUR | 880 | 2.853 | 5.996 | 3.129 | 3.350 | - | - | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
Check the financial reports for the company - Bio Product S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Current Assets | 3.074 | 5.762 | 11.308 | 14.252 | 17.323 | - | - | - | - | - |
| Inventories | 29 | 244 | 627 | 640 | 2.212 | - | - | - | - | - |
| Receivables | 10 | 10 | 10 | 762 | 10 | - | - | - | - | - |
| Cash | 3.035 | 5.507 | 10.671 | 12.850 | 15.101 | - | - | - | - | - |
| Shareholders Funds | -291 | 2.565 | 8.518 | 11.491 | 14.618 | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | - | - | - | - |
| Debts | 3.365 | 3.197 | 2.791 | 2.762 | 2.704 | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Bio Product S.r.l.